undamentalytics Newsletter

Hunt Anthony: insider trades

Chief executive, Director at Repligen Corp. 1 open-market purchase and 24 sales not made under a pre-set plan, reported from January 24, 2018 to November 14, 2025.

Would copying Hunt Anthony’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 1 purchase has 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on June 17, 2024 into $12,286 by November 2, 2026, +9.1% a year. The copy held shares only 10% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $11,247, +5.1% a year (the S&P 500 held throughout made $14,235, +16.1% a year). Beta against the index was 0.07. Twelve months after each report, the average purchase was −14.8% against the S&P 500 (median −14.8%), and 0% beat it. Measured from the trade date, the insider’s own timing, the average was −17.9%. After their sales, the shares moved +23.7% against the index over 12 months on average (a negative figure means selling was the right call); 39% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$5.0k$10.0k$15.0k 202420252026 $14.2k$12.3k$11.2k
Copying Hunt AnthonyS&P 500, same days investedS&P 500, held throughout $10,000 copying Hunt Anthony’s open-market purchases from June 17, 2024, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+9.1%
S&P 500, same days invested
+5.1% (held throughout +16.1%)
Time in shares
10%
Sharpe ratio (S&P 500)
0.33 (0.74)
Biggest drop (S&P 500)
−16% (−19%)
Market sensitivity (beta)
0.07
Purchases copied
1

Trade by trade

Hunt Anthony: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 1 +6.4% +6.4% 100% 1 — — Not enough years
Purchases, 6 months after the report 1 +17.8% +17.8% 100% 1 — — Not enough years
Purchases, 12 months after the report 1 −14.8% −14.8% 0% 1 — — Not enough years
Purchases, 12 months after the trade 1 −17.9% −17.9% 0% 1 — — Not enough years
Sales, 3 months after the report 24 +8.3% +9.7% 33% 7 1.51 0.18 No reliable evidence
Sales, 12 months after the report 23 +23.7% +33.1% 39% 7 1.40 0.21 No reliable evidence
Sales, 12 months after the trade 23 +24.2% +19.2% 39% 7 1.38 0.22 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Repligen Corp RGEN Chief Executive Officer124January 24, 2018November 14, 2025

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 14, 2025November 13, 2025 RGEN Sale $3,092,278 −11.0%not yetnot yet
September 11, 2025September 10, 2025 RGEN Sale $3,508,389 +37.3%+37.4%+18.9%
November 22, 2024November 21, 2024 RGEN Sale $3,386,439 +9.3%+1.3%+6.1%
June 14, 2024June 14, 2024 RGEN Purchase $248,160 +6.4%−14.8%−17.9%
November 14, 2022November 11, 2022 RGEN Sale $5,000,000 −9.0%−42.9%−37.2%
September 9, 2022September 8, 2022 RGEN Sale $5,933,438 −25.8%−42.0%−42.1%
July 22, 2022July 21, 2022 RGEN Sale $4,960,400 −10.3%−27.7%−29.1%
November 19, 2021November 18, 2021 RGEN Sale $4,804,674 −26.8%−24.1%−22.8%
September 13, 2021September 9, 2021 RGEN Sale $7,368,650 −17.5%−13.0%−12.6%
May 20, 2021May 19, 2021 RGEN Sale $3,816,698 +38.7%−9.3%−11.2%
March 12, 2021March 12, 2021 RGEN Sale $1,732,847 −12.0%−25.6%−22.2%
March 8, 2021March 4, 2021 RGEN Sale $4,165,091 −13.5%−24.2%−14.2%
November 23, 2020November 19, 2020 RGEN Sale $3,716,051 +13.4%+20.7%+19.2%
September 14, 2020September 10, 2020 RGEN Sale $6,721,018 +14.9%+63.6%+66.8%
May 26, 2020May 21, 2020 RGEN Sale $6,562,409 +1.7%−0.6%−14.7%
March 5, 2020March 3, 2020 RGEN Sale $1,301,793 +19.3%+61.4%+101.3%
February 27, 2020February 25, 2020 RGEN Sale $1,375,074 +49.7%+125.1%+126.1%
September 23, 2019September 19, 2019 RGEN Sale $298,398 +8.0%+68.6%+64.7%
September 11, 2019September 9, 2019 RGEN Sale $996,521 +10.0%+70.0%+61.6%
March 20, 2019March 18, 2019 RGEN Sale $867,628 +30.7%+61.7%+73.4%
March 5, 2019March 5, 2019 RGEN Sale $760,500 +31.2%+54.4%+47.9%
March 4, 2019February 28, 2019 RGEN Sale $441,100 +25.4%+47.9%+35.5%
September 12, 2018September 10, 2018 RGEN Sale $1,590,834 +11.2%+33.1%+31.7%
May 22, 2018May 21, 2018 RGEN Sale $691,070 +15.4%+55.4%+54.3%
January 24, 2018January 22, 2018 RGEN Sale $322,472 +8.3%+54.3%+55.5%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hunt Anthony traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.